Market Cap 5.10M
Revenue (ttm) 34.87M
Net Income (ttm) -5.13M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -14.71%
Debt to Equity Ratio 0.00
Volume 24,900
Avg Vol 35,898
Day's Range N/A - N/A
Shares Out 4.91M
Stochastic %K 40%
Beta 1.47
Analysts Strong Sell
Price Target $7.00

Company Profile

Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pa...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 954 330 0684
Address:
333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, United States
contra7
contra7 Apr. 4 at 3:05 PM
$SBFM The company released a clean, standard boilerplate 10k with zero red flags and continued house cleaning. Exactly what you would expect from a company that has been silent over 6 months,seemingly under NDA. They have initiated all the necessary steps to clean the cap tab presumably ahead of a significant corporate action. The 10k had to be released before a deal could be finalized, now they have top tier auditor M&K CPAS stamp of approval which clears the way for an 8k. Once a deal is signed an 8k has to be filed within 4 days. 🤞🏾
2 · Reply
MB66
MB66 Apr. 3 at 11:22 PM
$SBFM https://www.sec.gov/ix?doc=/Archives/edgar/data/0001402328/000168316826002644/sunshine_i10k-123125.htm
1 · Reply
Dmann32
Dmann32 Apr. 3 at 8:54 PM
$SBFM extended the reporting date so they could drop it when markets are closed , still losing money every quarter. They pay more in salaries than the actual market cap . They take from shareholders via dilution and stuff the executives pockets . There will be no miracle with this failed business model . Sell
1 · Reply
Kalini67
Kalini67 Apr. 3 at 8:17 PM
$SBFM We need to wait and see if they have PR with a projection for 2026 and waiting for the Patent approval Covid treatment can come out any day now, the one time loss they had 1.748 million was due to medicines licenses they though couldn't market or bring revenue to the Company...Still
1 · Reply
MS121
MS121 Apr. 3 at 7:43 PM
$SBFM Get ready for dilution + reverse split.
0 · Reply
Kalini67
Kalini67 Apr. 3 at 5:31 PM
$SBFM 4th Quarter released already, not looking good , 2025 Revenue 36.3 millions so only 4% invrease with 9.1 million in cash in hand , do mot say anything else
2 · Reply
Masterrunner
Masterrunner Apr. 2 at 11:56 PM
$SBFM Before loading up on “cheap” shares of SBFM, remember this infamous truth: “Slilaty will do what’s best for Slilaty; everyone else can F off.” If that doesn’t tell you where shareholders stand, nothing will. Happy Easter everyone 🐣📉
0 · Reply
RonRon1234
RonRon1234 Apr. 2 at 3:29 PM
$SBFM so we wait up to 15 business days from Monday?
1 · Reply
hotslots
hotslots Apr. 1 at 2:45 PM
$SBFM what about us???
2 · Reply
contra7
contra7 Mar. 31 at 11:37 PM
$SBFM One year to the day the company filed an NT-10K extension on March 31st, 2025 then dropped the 10K the next day on April 1st, for what it’s worth . No more announcement predictions for me, we shall see….still
1 · Reply
Latest News on SBFM
Sunshine Biopharma Launches a New Generic Prescription Drug

Dec 4, 2024, 4:05 PM EST - 1 year ago

Sunshine Biopharma Launches a New Generic Prescription Drug


Sunshine Biopharma Announces Reverse Stock Split

Aug 6, 2024, 8:00 AM EDT - 1 year ago

Sunshine Biopharma Announces Reverse Stock Split


Sunshine Biopharma Moves Principal Office to New York City

Dec 4, 2023, 8:30 AM EST - 2 years ago

Sunshine Biopharma Moves Principal Office to New York City


Sunshine Biopharma Announces Share Repurchase Program

Jan 19, 2023, 7:30 AM EST - 3 years ago

Sunshine Biopharma Announces Share Repurchase Program


Sunshine Biopharma's Annual Letter to Shareholders

Dec 20, 2022, 8:00 AM EST - 3 years ago

Sunshine Biopharma's Annual Letter to Shareholders


4 Stocks Meeting GuruFocus' Value Screens in December

Dec 5, 2022, 5:46 PM EST - 3 years ago

4 Stocks Meeting GuruFocus' Value Screens in December

RM CACC WFG


contra7
contra7 Apr. 4 at 3:05 PM
$SBFM The company released a clean, standard boilerplate 10k with zero red flags and continued house cleaning. Exactly what you would expect from a company that has been silent over 6 months,seemingly under NDA. They have initiated all the necessary steps to clean the cap tab presumably ahead of a significant corporate action. The 10k had to be released before a deal could be finalized, now they have top tier auditor M&K CPAS stamp of approval which clears the way for an 8k. Once a deal is signed an 8k has to be filed within 4 days. 🤞🏾
2 · Reply
MB66
MB66 Apr. 3 at 11:22 PM
$SBFM https://www.sec.gov/ix?doc=/Archives/edgar/data/0001402328/000168316826002644/sunshine_i10k-123125.htm
1 · Reply
Dmann32
Dmann32 Apr. 3 at 8:54 PM
$SBFM extended the reporting date so they could drop it when markets are closed , still losing money every quarter. They pay more in salaries than the actual market cap . They take from shareholders via dilution and stuff the executives pockets . There will be no miracle with this failed business model . Sell
1 · Reply
Kalini67
Kalini67 Apr. 3 at 8:17 PM
$SBFM We need to wait and see if they have PR with a projection for 2026 and waiting for the Patent approval Covid treatment can come out any day now, the one time loss they had 1.748 million was due to medicines licenses they though couldn't market or bring revenue to the Company...Still
1 · Reply
MS121
MS121 Apr. 3 at 7:43 PM
$SBFM Get ready for dilution + reverse split.
0 · Reply
Kalini67
Kalini67 Apr. 3 at 5:31 PM
$SBFM 4th Quarter released already, not looking good , 2025 Revenue 36.3 millions so only 4% invrease with 9.1 million in cash in hand , do mot say anything else
2 · Reply
Masterrunner
Masterrunner Apr. 2 at 11:56 PM
$SBFM Before loading up on “cheap” shares of SBFM, remember this infamous truth: “Slilaty will do what’s best for Slilaty; everyone else can F off.” If that doesn’t tell you where shareholders stand, nothing will. Happy Easter everyone 🐣📉
0 · Reply
RonRon1234
RonRon1234 Apr. 2 at 3:29 PM
$SBFM so we wait up to 15 business days from Monday?
1 · Reply
hotslots
hotslots Apr. 1 at 2:45 PM
$SBFM what about us???
2 · Reply
contra7
contra7 Mar. 31 at 11:37 PM
$SBFM One year to the day the company filed an NT-10K extension on March 31st, 2025 then dropped the 10K the next day on April 1st, for what it’s worth . No more announcement predictions for me, we shall see….still
1 · Reply
hotslots
hotslots Mar. 31 at 11:05 PM
$SBFM delayed because the buyout is so big....
0 · Reply
MB66
MB66 Mar. 31 at 8:39 PM
$SBFM always with these goons. https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=319920700&type=PDF&symbol=SBFM&cdn=7fd32a07776c6d2bf9edb048e9154d4b&companyName=Sunshine+Biopharma+Inc.&formType=NT+10-K&formDescription=Notification+of+inability+to+timely+file+Form+10-K+405%2C+10-K%2C+10-KSB+405%2C+10-KSB%2C+10-KT%2C+or+10-KT405&dateFiled=2026-03-31
0 · Reply
Kalini67
Kalini67 Mar. 31 at 8:22 PM
$SBFM I really believe the more likely day for earnings release will be Monday, by checking No, its really stange either because lawyers involved protecting the NDA or they didnt have more sales in 2025 change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements?”
0 · Reply
Kalini67
Kalini67 Mar. 31 at 8:06 PM
$SBFM Yup they filed for a delay so maybe tomorrow
1 · Reply
Ifcowshadtoes
Ifcowshadtoes Mar. 31 at 8:01 PM
0 · Reply
MB66
MB66 Mar. 31 at 5:23 PM
$SBFM wouldn’t be surprised to see an extension request filed at the 11th hours for their earnings report. Pretty standard practice with these jamokes.
2 · Reply
contra7
contra7 Mar. 31 at 11:29 AM
$SBFM 🤞🏾
0 · Reply
contra7
contra7 Mar. 31 at 2:57 AM
$SBFM Folks do not realize how explosive 🧨 this setup is….this may very well be a GME level event IMO
0 · Reply
contra7
contra7 Mar. 31 at 12:51 AM
$SBFM It is my understanding now that it is quite possible that a 10k drops tomorrow without a deal being formally announced but there should be strategic wording in the 10k that is used when deals are in the works but not yet finalized. If a deal is announced it will be accompanied by an 8k filing. The 10k would need to disclose the signing of an LOI if it happened anytime last year or between 12/31 and now. The Q1 ER is due between 4/6-4/10 which could be another targeted window for full disclosure. No I’m not kicking the can on my speculation, just getting a clearer understanding of how this situation can play out. Again, no formal deal announcement tomorrow does not mean there is no deal. My apologies for any confusion or misunderstandings on my behalf, I’m still learning on the fly🤷🏾‍♂️
1 · Reply
Kalini67
Kalini67 Mar. 31 at 12:02 AM
$SBFM Worse case scenario, Tuesday they will filed for an extension then releade earnings Wednesday , after all is what they did for the 4th quarter of 2024
0 · Reply
contra7
contra7 Mar. 30 at 11:09 PM
$SBFM Tuesday is actually the highest frequency day for SBFM to release positive news. I am certain that tomorrow will not be a standard “business as usual” 10k ER release. We have arrived at the inflection point and we will soon learn the fate of the company moving forward and its implications on our investments. Y’all already know what I think, my prediction was just a day early nothing has changed for me! NFA GLTA especially OG longs 🤞🏾
0 · Reply
contra7
contra7 Mar. 30 at 6:38 PM
$SBFM Volume at 30k right now let’s see if we get a volume surge into closing
0 · Reply